Medical Equipment

Transcatheter Mitral Valve Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

March 17, 2026March 17, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Transcatheter Mitral Valve Market Over The Period 2026–2030?

The transcatheter mitral valve market size has experienced robust growth in recent years. Its value is anticipated to rise from $1.61 billion in 2025 to $1.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. Several factors contributed to this historic period growth, including the limited availability of transcatheter mitral valves, a reliance on surgical valve replacement, increasing awareness of mitral valve disease, a rise in hospital cardiac procedures, and early adoption in high-risk patient groups.

The transcatheter mitral valve market is poised for substantial expansion over the next few years. It is projected to achieve a size of $2.49 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This anticipated growth is driven by several factors, including ongoing technological enhancements in transcatheter valve designs, an expanding elderly population experiencing mitral valve disorders, the increasing number of cardiac catheterization laboratories, rising healthcare spending, and the wider implementation of minimally invasive cardiac intervention programs. Key trends expected in the forecast period involve the increasing embrace of minimally invasive cardiac procedures, the growing application of self-expanding and balloon-expandable valves, the development and use of edge-to-edge and chordal repair devices, a rising incidence of mitral valve diseases among older demographics, and the integration of advanced imaging and navigation systems to improve procedural accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27437&type=smp

What Drivers Are Expected To Influence The Transcatheter Mitral Valve Market During The Forecast Period?

The anticipated rise in heart disease cases is set to boost the expansion of the transcatheter mitral valve market. These conditions involve disruptions to the heart’s structure or function, leading to decreased efficiency in blood pumping. The increasing occurrence of heart diseases is fueled by aging demographics, where age-related wear and tear on the heart and blood vessels heighten susceptibility to ailments like mitral valve regurgitation, heart failure, and arrhythmias. A transcatheter mitral valve aids in treating heart disease by repairing or substituting a compromised mitral valve, thereby reinstating proper blood flow between the heart’s chambers, enhancing cardiac function, and alleviating symptoms. For example, data from August 2025, provided by the National Center for Biotechnology Information, a US-based governmental agency, indicates a substantial projected increase in cardiovascular disease between 2025 and 2050. This includes a 90.0% rise in prevalence, a 73.4% increase in crude mortality, and a 54.7% surge in crude DALYs, culminating in an estimated 35.6 million cardiovascular deaths in 2050, up from 20.5 million in 2025. Consequently, the expanding incidence of heart diseases is a key factor propelling the growth of the transcatheter mitral valve market.

How Is The Transcatheter Mitral Valve Market Divided Into Its Major Segments?

The transcatheter mitral valve market covered in this report is segmented –

1) By Product: Transcatheter Mitral Valve Replacement, Transcatheter Mitral Valve Repair

2) By Indication: Mitral Stenosis, Mitral Regurgitation

3) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories

Subsegments:

1) By Transcatheter Mitral Valve Replacement: Self-Expanding Valves, Balloon-Expandable Valves

2) By Transcatheter Mitral Valve Repair: Annuloplasty Devices, Chordal Repair Devices, Edge-To-Edge Repair Devices

How Are Trends Transforming The Transcatheter Mitral Valve Market Landscape?

Companies operating within the transcatheter mitral valve market are primarily focused on developing advanced products, such as transcatheter mitral valve replacement systems, to broaden treatment possibilities for high-risk or inoperable patients. Transcatheter mitral valve replacement (TMVR) systems are defined as minimally invasive medical devices that replace a damaged or diseased mitral valve in the heart with an artificial valve using a catheter-based approach, thereby eliminating the need for open-heart surgery. For example, in May 2025, Abbott Laboratories, a US-based medical device company, introduced Tendyne, which secured approval from the Food and Drug Administration (FDA). This particular valve is self-expanding, nitinol-framed, comes in multiple sizes to accommodate various anatomies, and can be fully repositioned or retrieved during implantation. The system is delivered through a small incision in the chest, enabling a minimally invasive procedure typically finished in about 1.5 hours. Engineered for rapid recovery, the system allows most patients to be discharged within three days, offering a transformative solution for high-risk mitral valve patients who do not have viable surgical alternatives.

Who Are The Prominent Organizations Shaping The Transcatheter Mitral Valve Market?

Major companies operating in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd.

Read the full transcatheter mitral valve market report here:

https://www.thebusinessresearchcompany.com/report/transcatheter-mitral-valve-global-market-report

Which Region Is Forecast To Lead The Transcatheter Mitral Valve Market In Terms Of Market Size?

North America was the largest region in the transcatheter mitral valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter mitral valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Transcatheter Mitral Valve Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27437&type=smp

Browse Through More Reports Similar to the Global Transcatheter Mitral Valve Market 2026, By The Business Research Company

Titanium Market Report 2026

https://www.thebusinessresearchcompany.com/report/titanium-global-market-report

Carbon Nanomaterials Market Report 2026

https://www.thebusinessresearchcompany.com/report/carbon-nanomaterials-global-market-report

Aerospace Titanium Market Report 2026

https://www.thebusinessresearchcompany.com/report/aerospace-titanium-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795